|
LOC145783 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.129800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.401100E-03 |
| Normal-vs-Stage2 |
2.255800E-01 |
| Normal-vs-Stage3 |
7.404200E-01 |
| Normal-vs-Stage4 |
3.018600E-01 |
| Stage1-vs-Stage2 |
4.543800E-01 |
| Stage1-vs-Stage3 |
1.926380E-02 |
| Stage1-vs-Stage4 |
2.534000E-01 |
| Stage2-vs-Stage3 |
3.564400E-01 |
| Stage2-vs-Stage4 |
8.369800E-01 |
| Stage3-vs-Stage4 |
4.475400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.792020E-01 |
| Normal-vs-AfricanAmerican |
2.248100E-02 |
| Normal-vs-Asian |
1.351530E-02 |
| Caucasian-vs-AfricanAmerican |
1.038160E-01 |
| Caucasian-vs-Asian |
6.720000E-02 |
| AfricanAmerican-vs-Asian |
4.580600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.716600E-01 |
| Normal-vs-Female |
1.821870E-03 |
| Male-vs-Female |
1.904740E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.646600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.020300E-02 |
| Normal-vs-Age(61-80Yrs) |
8.711600E-02 |
| Normal-vs-Age(81-100Yrs) |
7.615800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.331620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.675600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.956500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.544000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.893600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.254800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.658100E-02 |
| Normal-vs-Grade 2 |
8.607800E-02 |
| Normal-vs-Grade 3 |
1.202830E-01 |
| Normal-vs-Grade 4 |
3.462000E-01 |
| Grade 1-vs-Grade 2 |
5.942300E-02 |
| Grade 1-vs-Grade 3 |
5.607500E-02 |
| Grade 1-vs-Grade 4 |
4.948100E-02 |
| Grade 2-vs-Grade 3 |
8.427400E-01 |
| Grade 2-vs-Grade 4 |
6.136400E-01 |
| Grade 3-vs-Grade 4 |
7.485000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.720200E-03 |
| Normal-vs-ccB subtype |
6.732200E-01 |
| ccA subtype-vs-ccB subtype |
3.06279999995329E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.936580E-01 |
| Normal-vs-N1 |
5.137800E-01 |
| N0-vs-N1 |
9.682600E-01 |
|
|
